IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,350,000 | -10.9% | 33,852 | +0.4% | 0.13% | -17.1% |
| Q1 2021 | $1,515,000 | +3.3% | 33,701 | +29.9% | 0.15% | 0.0% |
| Q4 2020 | $1,466,000 | -38.9% | 25,944 | -48.7% | 0.15% | -41.5% |
| Q3 2020 | $2,398,000 | +11.3% | 50,537 | +38.2% | 0.26% | +6.6% |
| Q2 2020 | $2,155,000 | +323.4% | 36,558 | +725.4% | 0.24% | +248.6% |
| Q1 2020 | $509,000 | +88.5% | 4,429 | -0.8% | 0.07% | +150.0% |
| Q4 2019 | $270,000 | +1.1% | 4,463 | 0.0% | 0.03% | 0.0% |
| Q3 2019 | $267,000 | +128.2% | 4,463 | +145.9% | 0.03% | +133.3% |
| Q2 2019 | $117,000 | – | 1,815 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |